Literature DB >> 2597311

Platelet monoamine oxidase-B activity in Parkinson's disease.

G B Steventon1, S G Sturman, M T Heafield, R H Waring, J Napier, A C Williams.   

Abstract

Platelet MAO-B levels have been investigated in seventeen consecutively diagnosed and previously untreated patients with idiopathic Parkinson's disease using the non-hydroxylated catecholamine, beta-phenylethylamine, as substrate. Patients with Parkinson's disease had MAO-B activity levels that were considerably higher than sex and age matched normal controls or patients with Motor neurone disease or Myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2597311     DOI: 10.1007/bf02263479

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  4 in total

1.  Ecogenetics, xenobiotic biochemistry and neurological disease.

Authors:  A Williams
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

Review 2.  Hereditary variation of liver enzymes involved with detoxification and neurodegenerative disease.

Authors:  A C Williams; G B Steventon; S Sturman; R H Waring
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis.

Authors:  Ying Liu; Zhiyun Wang; Benshu Zhang
Journal:  Ann Saudi Med       Date:  2014 Jan-Feb       Impact factor: 1.526

Review 4.  Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities.

Authors:  Benedetta Izzi; Alfonsina Tirozzi; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Marc F Hoylaerts; Licia Iacoviello; Alessandro Gialluisi
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.